Genomic Characterization of VIM and MCR Co-Producers: The First Two Clinical Cases, in Italy
Overview
Authors
Affiliations
Background: the co-production of carbapenemases and -genes represents a worrisome event in the treatment of infections. The aim of the study was to characterize the genomic features of two clinical complex (ECC) isolates, co-producing VIM and MCR enzymes, in Italy.
Methods: species identification and antibiotic susceptibility profiling were performed using MALDI-TOF and broth microdilution methods, respectively. Transferability of the and - type genes was verified through conjugation experiment. Extracted DNA was sequenced using long reads sequencing technology on the Sequel I platform (PacBio).
Results: the first isolate showed clinical resistance against ertapenem yet was colistin susceptible (EUCAST 2020 breakpoints). The gene was harbored on a conjugative IncHI2 plasmid, while the determinant was harbored on a conjugative IncN plasmid. The second isolate, resistant to both carbapenems and colistin, harbored: gene and its two component regulatory genes for increased expression on the chromosome, on non-conjugative (yet co-transferable) ColE plasmid, and on a non-conjugative IncA plasmid.
Conclusions: to our knowledge, this is the first report of co-production of VIM and MCR in ECC isolates in Italy.
Zelendova M, Papagiannitsis C, Sismova P, Medvecky M, Pomorska K, Palkovicova J Front Microbiol. 2023; 14:1147846.
PMID: 37180238 PMC: 10174314. DOI: 10.3389/fmicb.2023.1147846.
Jamin C, Brouwer M, Veldman K, Beuken E, Witteveen S, Landman F JAC Antimicrob Resist. 2023; 5(3):dlad053.
PMID: 37153697 PMC: 10155863. DOI: 10.1093/jacamr/dlad053.
Guarneri F, Bertasio C, Romeo C, Formenti N, Scali F, Parisio G Antibiotics (Basel). 2023; 12(4).
PMID: 37107051 PMC: 10134971. DOI: 10.3390/antibiotics12040689.
Bitar I, Papagiannitsis C, Kraftova L, Mattioni Marchetti V, Petinaki E, Finianos M Front Microbiol. 2023; 13:993240.
PMID: 36687644 PMC: 9845580. DOI: 10.3389/fmicb.2022.993240.
Formenti N, Guarneri F, Bertasio C, Parisio G, Romeo C, Scali F Antimicrob Resist Infect Control. 2022; 11(1):155.
PMID: 36494741 PMC: 9734789. DOI: 10.1186/s13756-022-01194-9.